AMRIC have consolidated all existing CPE guidance into one overall consolidated guidance document V1.0 Management and Control of Carbapenemase Producing Enterobacterales (CPE) in all Healthcare Settings as at 20.12.22.
Please note Guidelines for control and prevention of MDRO excl MRSA in healthcare setting is no longer available. It has been replaced by NCEC National Clinical Guideline No. 30 Infection Prevention and Control which is available at the following link https://www.gov.ie/en/department-of-health/publications/infection-prevention-and-control-ipc/
[file id=4450 name=Management and Control of Carbapenemase Producing Enterobacterales (CPE) in all Health and Social Care Settings]
[file id=4437 name=Guidance relating to the control of CPE and other AMRO in the Irish Prison Service]
Irish Guidance
[file id=4438 name=Guidance relating to healthcare workers colonised with CPE]
[file id=4439 name=A guide to treatment of infection with carbapenem resistant organisms]
International Guidance
ECDC Guidance – Rapid risk assessment – Carbapenem-resistant Enterobacterales – third update
Published 2025
Leave a Reply